For morbid obesity, one of the treatment options that have been deemed the most effective is
bariatric surgery. Specifically, endoscopic sleeve gastrectomy (ESG) has emerged as one of …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease
worldwide. Endoscopic sleeve gastroplasty (ESG) has proven to be feasible, safe, and …

Obesity is a chronic, relapsing, degenerative, multifactorial disease that is associated with
many co-morbidities. The global increasing burden of obesity has led to calls for an urgent …

Background Different treatment modalities are available for obesity management, including
lifestyle changes, pharmacotherapy, endoscopic interventions, and surgeries. Limited …

Obesity has reached pandemic levels globally. Surgical management of obesity aims to
establish metabolic control, weight loss and resolution of multiple health conditions and to …

Obesity rates have increased, and so has the need for more specific treatments. This trend
has raised interest in non-surgical weight loss techniques that are novel, safe, and …

Obesity is one of the most debilitating conditions. In a quest to mitigate disease severity,
various interventions have been proposed, with endoscopic sleeve gastroplasty (ESG) and …

Background: Bariatric endoscopy has emerged for non-surgical treatment of obesity,
providing a treatment option for weight loss and associated comorbidities. Outcomes of …

Obesity is a complicated, multifaceted, and largely preventable condition that is a growing
worldwide public health concern. Multiple metabolic syndromes such as hypertension, non …

Metabolic syndrome is a global health problem and a major public health priority [1]. A
recent burden of disease study estimated a prevalence of metabolic syndrome of 2.8%(∼ …